AU Stock MarketDetailed Quotes

Microba Life Sciences Ltd (MAP)

Watchlist
  • 0.090
  • -0.010-10.00%
20min DelayMarket Closed Jan 16 16:00 AET
54.81MMarket Cap-2.73P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Microba Life Sciences Ltd (MAP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Total revenue
29.60%15.67M
123.06%12.09M
15.60%5.42M
4.69M
Operating revenue
29.60%15.67M
123.06%12.09M
15.60%5.42M
--4.69M
Cost of revenue
33.03%8.23M
125.56%6.18M
18.04%2.74M
2.32M
Gross profit
26.01%7.44M
120.49%5.91M
13.21%2.68M
2.37M
Operating expense
-2.13%32.05M
42.95%32.75M
22.91%22.91M
18.64M
Selling and administrative expenses
35.85%17.61M
52.49%12.97M
-6.71%8.5M
--9.11M
-Selling and marketing expense
-15.78%662.29K
13.52%786.35K
28.11%692.71K
--540.71K
-General and administrative expense
39.19%16.95M
55.95%12.18M
-8.91%7.81M
--8.57M
Research and development costs
-81.47%2.01M
16.05%10.84M
73.43%9.34M
--5.38M
Depreciation amortization depletion
54.38%4.43M
74.82%2.87M
6.41%1.64M
--1.54M
-Depreciation and amortization
54.38%4.43M
74.82%2.87M
6.41%1.64M
--1.54M
Other operating expenses
31.60%8M
77.30%6.08M
31.95%3.43M
--2.6M
Operating profit
8.32%-24.61M
-32.69%-26.84M
-24.32%-20.23M
-16.27M
Net non-operating interest income (expenses)
-56.53%406.67K
14.42%935.51K
14,349.51%817.64K
-5.74K
Non-operating interest income
-41.94%583.36K
14.43%1M
1,672.01%878.05K
--49.55K
Non-operating interest expense
458.68%103.91K
13.35%18.6K
97.53%16.41K
--8.31K
Total other finance cost
43.77%72.78K
15.04%50.62K
-6.34%44K
--46.98K
Other net income (expenses)
54.72%9.16M
-12.17%5.92M
39.89%6.74M
4.82M
Other non-operating income (expenses)
54.72%9.16M
-12.17%5.92M
39.89%6.74M
--4.82M
Income before tax
24.73%-15.05M
-57.72%-19.99M
-10.59%-12.67M
-11.46M
Income tax
-107.77%-106.59K
-1,009.16%-51.3K
-38.86%5.64K
9.23K
Earnings from equity interest net of tax
Net income
25.07%-14.94M
-57.24%-19.94M
-10.55%-12.68M
-11.47M
Net income continuous operations
25.07%-14.94M
-57.24%-19.94M
-10.55%-12.68M
---11.47M
Noncontrolling interests
Net income attributable to the company
25.07%-14.94M
-57.24%-19.94M
-10.55%-12.68M
-11.47M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
25.07%-14.94M
-57.24%-19.94M
-10.55%-12.68M
-11.47M
Diluted earnings per share
31.48%-0.0333
-27.78%-0.0486
21.60%-0.038
-0.0485
Basic earnings per share
31.48%-0.0333
-27.78%-0.0486
21.60%-0.038
-0.0485
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Total revenue 29.60%15.67M123.06%12.09M15.60%5.42M4.69M
Operating revenue 29.60%15.67M123.06%12.09M15.60%5.42M--4.69M
Cost of revenue 33.03%8.23M125.56%6.18M18.04%2.74M2.32M
Gross profit 26.01%7.44M120.49%5.91M13.21%2.68M2.37M
Operating expense -2.13%32.05M42.95%32.75M22.91%22.91M18.64M
Selling and administrative expenses 35.85%17.61M52.49%12.97M-6.71%8.5M--9.11M
-Selling and marketing expense -15.78%662.29K13.52%786.35K28.11%692.71K--540.71K
-General and administrative expense 39.19%16.95M55.95%12.18M-8.91%7.81M--8.57M
Research and development costs -81.47%2.01M16.05%10.84M73.43%9.34M--5.38M
Depreciation amortization depletion 54.38%4.43M74.82%2.87M6.41%1.64M--1.54M
-Depreciation and amortization 54.38%4.43M74.82%2.87M6.41%1.64M--1.54M
Other operating expenses 31.60%8M77.30%6.08M31.95%3.43M--2.6M
Operating profit 8.32%-24.61M-32.69%-26.84M-24.32%-20.23M-16.27M
Net non-operating interest income (expenses) -56.53%406.67K14.42%935.51K14,349.51%817.64K-5.74K
Non-operating interest income -41.94%583.36K14.43%1M1,672.01%878.05K--49.55K
Non-operating interest expense 458.68%103.91K13.35%18.6K97.53%16.41K--8.31K
Total other finance cost 43.77%72.78K15.04%50.62K-6.34%44K--46.98K
Other net income (expenses) 54.72%9.16M-12.17%5.92M39.89%6.74M4.82M
Other non-operating income (expenses) 54.72%9.16M-12.17%5.92M39.89%6.74M--4.82M
Income before tax 24.73%-15.05M-57.72%-19.99M-10.59%-12.67M-11.46M
Income tax -107.77%-106.59K-1,009.16%-51.3K-38.86%5.64K9.23K
Earnings from equity interest net of tax
Net income 25.07%-14.94M-57.24%-19.94M-10.55%-12.68M-11.47M
Net income continuous operations 25.07%-14.94M-57.24%-19.94M-10.55%-12.68M---11.47M
Noncontrolling interests
Net income attributable to the company 25.07%-14.94M-57.24%-19.94M-10.55%-12.68M-11.47M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 25.07%-14.94M-57.24%-19.94M-10.55%-12.68M-11.47M
Diluted earnings per share 31.48%-0.0333-27.78%-0.048621.60%-0.038-0.0485
Basic earnings per share 31.48%-0.0333-27.78%-0.048621.60%-0.038-0.0485
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +16.46%
Sample Name
Sample Code
 +15.85%
Sample Name
Sample Code
 +12.83%
4
BIDU-SW
09888
+5.53%
5
JD HEALTH
06618
+4.39%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -